Roche Holding AG

Common Stock · USD · OTC

RHHBYT212

Price

$52.31

-0.02%

Cap

—

Earnings

—

30d Trend

+2.3%

0TDF

Loading chart data...

0 days · % change from startPowered by Brain47

VolatilityModerate

26% annualised over 90 days

BRAIN47 SIGNAL

STRONG

Risk Level38

Quality80

Momentum73

Technical55

Fundamentals57

Raw weighted: 66×Macro 0.99 (−1%)=65

RISK

38/100

90d Volatility

26.2%Moderate

ATR %

1.9%Normal

Max Drawdown (1Y)

-19.3%Normal

QUALITY

80/100

ROE (avg)

37.3%Excellent

Piotroski F-Score

6/9Average

Margin Stability

CV 3.1%Very stable

Accruals

-5.9%Cash earnings

Interest Coverage

13.7xVery comfortable

MOMENTUM

73/100

12-1M Momentum

+32.8%Strong uptrend

6-1M Momentum

+9.1%Positive

1M Return

+3.9%Stable

Relative Strength

-0.2% vs sectorIn-line

TECHNICAL

55/100

RSI (14)

56.8Neutral

Price vs SMA200

+9.6%Bullish trend

MACD

+0.13Bullish momentum

Bollinger Band

77%Mid-range

SMA Cross

Death CrossDeath Cross

Trend Quality (KER)

0.236Noisy/choppy

FUNDAMENTALS

57/100

EV/EBIT

17.5Fair

P/FCF

25.2Fair

P/S

5.2Fair

PEG

1.39Fair growth

Shareholder Yield

2.3%Moderate

Macro: neutral (×0.99) - Fear/Greed: 65 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months54

3-12 months59

1-5+ years ★69

Long-term compounder with 2.3% yield

BRAIN47'S ASSESSMENT

I rate Roche Holding AG at 65/100 — a STRONG reading on the Brain47 Signal. The strongest factor is quality at 80/100. I classify this as a growth position with the strongest thesis on a long-term horizon.

PAST PERFORMANCE

1 MONTH

+3.9%

3 MONTHS

-9.3%

12 MONTHS

+36.7%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Long-term compounder with 2.3% yield. Quality (80) and Momentum (73) are the primary strengths. Historical volatility is moderate at 26%. I classify this as a growth position — strong momentum combined with solid fundamentals points to capital appreciation.

growthScore: 65/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.